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tion surface was found (r = 0.7). Attachment of the SAM to the mitral valve
was present in 14 patients and confirmed by surgical view in 7 patients.
Conclusion: 3DE introduces new pre-operative description of the SAM.
Such views could optimize the surgical indication and procedure. 
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Background: End-stage ventricular dysfunction is the most common cause
of mortality in adults with FUVH. The physiopathology of this condition
remains unclear.
End-stage dilated as well as hypertrophic cardiomyopathies experience
reduced capillary density. In FUVH physiology, volume overload leads to ven-
tricular dilatation, followed by myocardial hypertrophy. We therefore hypoth-
esize that FUVH also demonstrate a reduced capillary density.
Methods: Average capillary density was measured in 13 post-mortem
human adult hearts: 5 failing FUVH and 8 controls. Hearts were preserved in
10% formalin. Free wall left ventricular longitudinal and transversal tissue
specimens were harvested below the level of mitral valve papillary muscles. A
morphometric study was realized after immunohistochemical staining of factor
VIII. Capillary surface area was quantified by optical density on 50 different
samples per patient. The capillary density was calculated: (capillary surface
area) / (total ventricular surface area) (x100%) using Image J software.
Results were expressed as mean ± sd.
Results:Among the 13 hearts, 6 allowed a correct interpretation of the cap-
illary density: 3 FUVH (2 tricuspid atresia, 1 double-inlet left ventricle, all
with end-stage ventricular dysfunction) and 3 controls (congenital heart dis-
ease with normal left ventricular function : 2 atrial septal defects with Eisen-
menger syndrome, 1 tetralogy of Fallot with pulmonary atresia). There was no
significant difference in arterial oxygen saturation between the 2 groups (71 ±
1% in FUVH vs 85 ± 0,8% in controls). Myocardial capillary density was sig-
nificantly decreased in FUVH compared to controls (3.58 ± 1.23% vs 7.69 ±
3.29%, p<0.0001).
Conclusion: Myocardial capillary density is decreased in end-stage failing
functionally univentricular hearts. Yet, further studies with a larger amount of
patients are needed to assert the responsibility of the decreased capillary den-
sity for the ventricular dysfunction.
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Objective: To asses the evolution of prenatal diagnosis (PD) of congenital
heart diseases (CHD) for the population of Indre-et-Loire, a French depart-
ment.
Method: Retrospective analysis of the quantitative and qualitative datas of
PD between 2000 and 2005 (period 3) and comparison to studies conducted
from 1991 to 1994 (period 1) and from 1995 to 1999 (period 2). The CHD
considered as detectable are the major CHD with neonatal symptoms.
Results: Period 3: 65.7% of detectable CHD were screened. Using the cri-
teria of PD of period 1, the percentage of CHD detected for periods 1,2 and 3
is respectively 43.2%, 66.7% and 79.3%. For transposition of the great
arteries: 25%, 62.5% and 60%. For hypoplasic left ventricle: 80%, 87.5% and
94.1%. Tetralogy of Fallot: 10%, 42.8% and 75%. Pulmonary atresia with ven-
tricular septal defect: not studied, 50% and 100%. Severe coarctation of the
aorta: not studied, 25%, 40%. Atrio-ventricular septal defect: 77%, 77% and
80%. Diagnoses made by a Pediatric-cardiologist are correct and complete in
80% of cases.
Discussion: Performance of PD of CHD is comparable to those reported in
the literature. The improvement of PD over time is due to technological
progress, greater experience of ultrasonographers and to the systematic visual-
ization of outflow tract in addition to the four chamber view.
Conclusion: despite the improvement of PD, some life threatening CHD
are not screened before birth and require a specific training program for the
ultrasonographers.
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Introduction: The literature demonstrated that children receiving anticoag-
ulation therapy require more frequent monitoring than their adult counterparts
due, in part, to the complexity of their underlying medical conditions. Since
June 2008, point-of-care International Normalized Ratio (POC INR) monitor
are refund by Social Security in France for paediatric patients. The aim of this
study is to evaluate the outcomes of home INR monitoring in children through
a standardized education and training program.
Materials and methods: The POC INR monitor is refund for under eigh-
teen patients with a cardiologic or non cardiologic indications. Participating
parents had to complete a one-day intensive education and training program.
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After demonstrating theoretical and practical competences, parents com-
menced home monitoring. We analysed the proportion of INR within the
target range, the incidence of anticoagulant related adverse events and the
quality of life of children and parents.
Results: We included 48 children (between 2 months and 17 years old).
Eighteen patients had a mitral valve replacement and 6 an aortic valve replace-
ment. Fifteen patients had a total cavopulmonary derivation, 7 a dilated cardi-
omyopathy, 1 coronary aneurysms after Kawasaki disease and 1 an
antiphospholipid syndrome. Twenty-eight patients received anticoagulation
therapy for the first time and 20 had been treated for a long time and switched
from venipuncture to point-of-care monitor. The results of the theoretical test
of parents were excellent (average 17.3/20). Only 3 families had practical dif-
ficulties at home. 65% of INRs were within the target range. There were no
haemorrhagic and thrombosis complications. The quality of life was improved.
Conclusion: This education and training program was perfectly safe and
improved the quality of life of patients and parents. The use of similar educa-
tion program may serve to improve the outcomes of home monitoring for anti-
coagulation therapy in children.
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The aim of this retrospective study was to describe features ofinfective
endocarditis (IE) in adults with congenital heart disease (CHD).
Methods: The records of all episodes of IE diagnosed from 1974, in
patients with CHD and more than 18 years of age at diagnosis, were retrospec-
tively reviewed.
Results: Fourty-four episodes of IE occurred, 36 after 1990 (81.8%), 28 males
(63.6%). Age at diagnosis was 30.3±9years (median 28years). Ten were recurrent
episodes (22.7%). CHD was previously repared in 15 cases (34%), palliated in 7
(16%) and non-operated in 22 (50%). Dental causes were predominant (34%),
followed by cutaneous causes (25%) ; others were postoperative (4.5%), miscel-
laneous (7%) or unknown causes (29.5%). A microbial agent as identified in
95.4% of the cases : oral streptococcus and staphylococcus aureus were the
leading causative agents (respectively 41% and 36%). Left heart locations were
predominant (75%). Severe clinical cardiac complication occurred in 10 cases
(23%), an echocardiographic complication in 18 (40%). Twenty-four patients
experienced embolic events (54.5%) ; early surgical treatment was required in
25% of the cases. Three patients died due to IE (6.8%). Antibiotic prophylaxis
had been neglicted despite known risk in 41% of the cases.
Conclusion: IE is an ongoing life-threatening complication in adults with
CHD, with a significant morbidity, a high rate of prophylaxis negligence and
of recurrence.
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Introduction: Pulmonary arterial hypertension (PAH) is a devastating dis-
ease with poor survival but there are limited data describing its impact in the
paediatric population.
Objective: The objectives of this national prospective registry were to col-
lect clinical and epidemiological data and to investigate the outcome of chil-
dren with PAH.
Methods: All consecutive patients <18 years with PAH seen in 16 referral
PAH centres in France were included and evaluated after 1 and 2 years of follow-
up for WHO functional class (FC), 6-minute walk distance (6MWD) and quality
of life (QoL; CHQ-PF50 questionnaire). Persistent pulmonary hypertension of the
newborn and PAH due to congenital heart disease (CHD) were excluded.
Results: Fifty patients were included between May 2005 and June 2006. Mean
age at diagnosis was 8.7 ± 5.4 years and male/female ratio was 1/1. The preva-
lence of pediatric PAH was 4.2 cases/million. A history of prematurity, cancer and
major surgery was noticed in respectively 19%, 6% and 4% of patients. At inclu-
sion, 28% of patients were in WHO FC III or IV. Aetiology of PAH was idio-
pathic in 60%; familial in 10%, associated with but not due to CHD in 24%,
related to connective tissue disease in 4% and to portal hypertension in 2%.
Nine patients (018%) died during the 2-year follow up. Survival estimates
at 1 and 2 years were 86% and 82%. Seventy three percents of patients
improved or did not change WHO FC (n = 44). Patients remained stable
regarding 6MWD (n = 25), hemodynamics (n = 11), and QoL (n = 19). During
the 2-year follow-up, combination of PAH-specific therapies was increasingly
prescribed (44% patients vs. 22% at inclusion).
Conclusions: This first national paediatric registry showed (1) the presence
of multiple PAH aetiologies in children, that could be different from those
seen in adults, (2) the association with other co-morbidities, and (3) the stabi-
lization or even improvement in patient’s condition with the therapeutic man-
agement recommended in the current era.
314
Outcomes and prognosis in patient with TGFBR2 or FBN1 gene
mutation
David Attias (1), Chantal Stheneur (1), Carine Roy (2), L. Faivre (3),
Gwenaelle Collod-Beroud (4), Delphine Detaint (1), M.A. Delrue (5), H.
Plauchu (6), Mireille Claustres (4), S. Lyonnet (7), A. Vahanian (8),
Catherine Boileau (1), Guillaume Jondeau (1)
(1) AP-HP, Hôpital Bichat, Consultation multidisciplinaire Marfan, Paris,
France – (2) AP-HP, Hôpital Bichat, Biostatistique et Recherche Clinique,
INSERM, U738, Paris, France – (3) Hopital des enfants, Dijon, France –
(4) INSERM U827, Montpellier, France – (5) Hopital Pellegrin enfants,
Bordeaux, Bordeaux, France – (6) Hopital Hotel Dieu, Lyon, France – (7)
Hopital Necker, Paris, France – (8) Hopital Bichat, Service Cardiologie,
Paris, France
Background: TGFBR2 mutations were recently recognized among
patients with a Marfan-like phenotype and have been associated with poor car-
diovascular prognosis (early deaths, aortic dissections or early surgery for tho-
racic ascending aorta aneurysm).
Methods: Clinical features and outcomes were analysed in a group of 71
patients (including 22 children) with a TGFBR2 mutation. Patients were com-
pared with age- and gender-matched patients harbouring the FBN1 mutation
(FBN1 group n=243).
Results: The proportion of patients with aortic dilatation was similar in the
TGFBR2 group and in the FBN1 group in both adults [74 % vs. 76 %] and
children [86 %vs. 86 %] and aortic dilatation was very variable in both
TGFBR2 and FBN1 groups.
The incidence and average age of thoracic aortic surgery for aortic dissec-
tion or aortic dilatation were similar in the 2 groups (31% vs. 27% and 35±16
vs. 39±13 years, NS).
Both the frequency and the age of occurrence of aortic dissection were sim-
ilar in the TGFBR2 and the FBN1 groups for the ascending aorta [14 % vs. 10
%, p=0.26; 38±12 vs. 39±9 years, p=0.82] and for the descending aorta (3/71
vs. 8/243, p=0.72; 34±6 vs. 44±10 years, p=0.16).
